500mg Erythromycin Estolate Tablets USP

₹ 1,103/Box

Strength500 mg
Packaging Size5 x 3 x 10 Tablets
Packaging TypeBox
Brand NameAlthrocin
ManufacturerAlembic Pharmaceuticals Ltd
Usage/ApplicationClinic, Hospital
FormTablets
Type Of MedicinesAllopathic
Country of OriginMade in India
AvailabilityIn Stock
We are engaged in offering 500mg Erythromycin Estolate Tablets USP to our clients. Our range of all products is widely appreciated by our clients.

Exports To: United States Of America | Bangladesh | Germany | Canada | The Netherlands

Find products similar to 500mg Erythromycin Estolate Tablets USP

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromSurat
ShippingAs per delivery location

Product Video

Product Image

500mg Erythromycin Estolate Tablets USP-1500mg Erythromycin Estolate Tablets USP-2500mg Erythromycin Estolate Tablets USP-3500mg Erythromycin Estolate Tablets USP-4500mg Erythromycin Estolate Tablets USP-5500mg Erythromycin Estolate Tablets USP-6

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
29-05-2023
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
0 - 40 L
IndiaMART Member Since
Apr 2023
GST
24EIXPR1363G1ZS
Import Export Code (IEC)
EIXPR*****
Exports to
United States Of America | Bangladesh | Germany | Canada | The Netherlands

Established in the year of 2017, We “Curisto Pharmaceutical” are Wholesaler, Retailer and Exporter of an Pharmaceutical Tablets, Capsule, Injection, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Rajput Sangramsing Vijaysing , whose continual backing and direction have been useful to us for attaining exponential development in the current market.